Concepedia

Christopher Dobie

CD

Statistics

Publications

4

Citations

52

H-Index

4

Active since

2017

Affiliations

University of Wollongong(Current)

Illawarra Health and Medical Research Institute

Christopher Dobie is an author at University of Wollongong specializing in lead compound design, drug discovery, and enzyme inhibition.

Publications per year

2017–2024

4

Publications

4

Design, synthesis and evaluation of carbamate-linked uridyl-based inhibitors of human ST6Gal I

Andrew P. Montgomery, Christopher Dobie, Rémi Szabo et al. · Bioorganic & Medicinal Chemistry · 2020 · 18 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Neutron Capture Enhances Dose and Reduces Cancer Cell Viability in and out of Beam During Helium and Carbon Ion Therapy

Nicholas Howell, Ryan J. Middleton, Frédéric Sierro et al. · International Journal of Radiation Oncology*Biology*Physics · 2024 · 12 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Computer‐aided design of human sialyltransferase inhibitors of hST8Sia III

Christopher Dobie, Andrew P. Montgomery, Rémi Szabo et al. · Journal of Molecular Recognition · 2017 · 11 citations

Medicine, Oncology, Pharmacology +14

Synthesis and biological evaluation of selective phosphonate-bearing 1,2,3-triazole-linked sialyltransferase inhibitors

Christopher Dobie, Andrew P. Montgomery, Rémi Szabo et al. · RSC Medicinal Chemistry · 2021 · 11 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

1–4 of 4